Citations

Introduction Although Valsalva maneuvers and strenuous exercise are commonly discouraged in patients with intracranial aneurysms (IAs), the cerebrovascular stress they induce remains poorly characterized. To our knowledge, no prior review has systematically quantified their effects on hemodynamic surrogates of rupture risk. Objective To characterize the acute intracranial hemodynamic effects of strenuous physical activity and Valsalva maneuvers in individuals with and without IAs. Methods We searched PubMed, Embase, Scopus, Web of Science, and Cochrane (February 2025; PROSPERO ID: CRD42025637608) following PRISMA. Eligible studies reported acute changes in SBP, ICP, central venous pressure (CVP), cerebrovascular transmural pressure (CVTMP), middle cerebral artery (MCA) velocity, or CFD‐derived parameters (wall shear stress [WSS], oscillatory shear index [OSI], relative residence time [RRT]) in response to physical exertion or Valsalva. Populations included individuals with or without IAs. Acute neurological symptoms were also reviewed. Results From 2,859 records, 14 studies met inclusion criteria. Eight studies assessed real‐time hemodynamic responses during exercise (91 participants without IAs). Three studies (n=39) showed that resistance exercise increased SBP (mean Δ+21.8 mmHg). Two studies (n=22) showed significant MAP elevation (mean Δ+24.7 mmHg). When combined with a Valsalva maneuver, SBP increased further (mean Δ+26 mmHg; range 20–30). Three studies (n=38) evaluating isolated Valsalva identified significant ICP elevation (mean Δ+15 mmHg; range 5.7–24.3), primarily driven by CVP increases (mean Δ+52.0 mmHg; range 39–56). Breath‐holding during exertion reduced MCA velocity (mean Δ–11.6 cm/s), while continuous ventilation preserved more stable flow. In seven patients, resistance exercise without Valsalva increased CVTMP by 24.5%. In contrast, Valsalva alone raised ICP and CVP without increasing SBP, yielding a CVTMP 11% lower than during exercise alone. These paired observations suggest that Valsalva may transiently offset exercise‐induced transmural stress by raising ICP alongside SBP. However, this effect may be time‐limited and reverse during early recovery—when SBP remains elevated as ICP quickly normalizes—potentially producing a CVTMP rebound above exercise‐only levels. Six CFD studies (11 aneurysms; diameter 6.3–23 mm; 2 ruptured) reported exercise‐related increases in time‐averaged WSS (mean +21.7%, range –4.4% to +50%) and peak WSS (mean +382.3%, range +100% to +628%). Exercise‐induced changes in heart rate and flow pulsatility led to complex redistributions of intra‐aneurysmal WSS, potentially exposing the aneurysmal wall to focal mechanical stress. Conclusion Resistance exercise, especially with breath‐holding, provokes dynamic, time‐sensitive cerebrovascular stress. Valsalva maneuver may transiently lower CVTMP during effort, yet its release with lingering SBP elevation can precipitate delayed transmural pressure surges. The proposed biphasic effect of Valsalva offers a novel conceptual framework for prospective. Our findings underscore the need to define safe, individualized activity thresholds for patients with IAs with patient‐specific validation integrating concurrent physiology and CFD to reduce the risk of IA growth and rupture.

Introduction The risk of aneurysmal subarachnoid hemorrhage (aSAH) during exercise is not well quantified. We assessed temporal clustering of aSAH around physical exertion and around Valsalva‐like activities (defecation or urination). Objectives To estimate the proportion of aSAH cases temporally linked to strenuous activities using reported exposure‐to‐onset window uwing within‐person odds of rupture from case‐crossover studies. Methods We searched PubMed/MEDLINE, Embase, Scopus, Web of Science, and the Cochrane Library from inception through January 2025, and hand‐searched reference lists (PRISMA‐aligned; PROSPERO CRD42025637608). Eligible studies reported the activity at aSAH onset or within a defined pre‐onset window. Exposures were analyzed separately (exertion; defecation/urination). Primary proportional estimates used each study's own exposure‐to‐onset window as reported. To improve comparability, subgroup analysis was performed with only a prespecified subset pooled consecutive case series that explicitly used a ≤2‐hour window between the index activity and aSAH. Within‐person odds ratios (ORs) were abstracted from case‐crossover studies. Risk of bias for observational exposure studies was assessed with ROBINS‐E by two independent reviewers. Results Sixteen studies (published 1980–2022) from 10 countries were included with 5,815 cases of aSAH (mean age 55 years; 60.6% female). Designs comprised 10 case series, 3 case reports, 2 case‐crossover studies, and 1 case‐control study. Activity‐at‐onset was recorded for 4,219/5,815 (72.6%); among these 4,219 patients, mean age was 52.7 years. Using each study's reported window, 308/4,219 (7.3%) aSAH occurred during or within the study‐defined window after physical exertion, and 387/4,219 (9.2%) during/within the window after defecation or urination 695/4,219 (16.5%) were temporally linked to either exposure. In the subset of 10 consecutive case series restricted to ≤2 hours, 275 (5.4%) were linked to exertion and 385 (7.6%) to defecation/urination (combined 660; 13.0%). Study‐specific proportions ranged from 0.8–21.3% for exertion and 2.0–15.4% for defecation/urination. Two case‐crossover studies reported higher within‐person odds of rupture after moderate‐to‐vigorous exertion (OR 2.4–2.7). Temporal clustering of aSAH around exertion or straining was observed in 13–17% of cases, depending on dataset and inclusion criteria. Conclusions Although this relatively high rate of temporal association between aSAH and exercise might suggest an increased risk of aneurysm rupture during strenuous activity, variable definitions and unstated exposure‐to‐onset windows do not permit causal inference. Prospective or registry‐embedded case‐crossover studies using standardized exposure definitions (intensity, duration) and objective exposure capture are needed to refine immediate‐risk estimates and identify patient‐level susceptibility modifiers.

Introduction Chronic internal carotid artery occlusion (CICAO) can result in recurrent ischemic events despite optimal medical therapy. Revascularization may serve as salvage treatment for symptomatic patients who fail medical management. Objective To evaluate the clinical outcomes of endovascular revascularization in patients with symptomatic CICAO. Methods We reviewed consecutive cases of symptomatic CICAO (symptoms ≥4 weeks) undergoing attempted endovascular revascularization between 2011 and 2024. Occlusions were classified as typical (complete) or atypical (pseudo‐occlusion or distal reconstitution via vasa‐vasorum). Outcomes included periprocedural complications (≤24 hours), technical failure, and new ischemic stroke or TIA during follow‐up. Functional status was assessed using the mRS before and after the procedure, with a favorable outcome defined as mRS ≤2. Results Twenty‐five patients were included (21 male; 84%), mean age 67.8 (range: 51‐81). Prior stroke was reported in 18 patients (72%) and TIA in in 13 (52%). Fourteen patients’ occlusion was at the level of the bifurcation (56%), nine at the cervical level (36%), one at the level of the mandible (4%) and one at the level of the common carotid artery (4%). The mean follow‐up duration was 23.1 ± 38.3 months. Dual antiplatelet therapy was used in 15 patients (60%), and single‐agent therapy in eight (32%). Technical treatment success, defined as adequate recanalization of the treated artery, was achieved in 20 (80%) patients, representing 13 of 18 patients from the typical group and all seven from the atypical group. Five patients (20%) failed the endovascular revascularization attempt and were treated with EC‐IC bypass instead (all from typical group). Periprocedural complications occurred in 11 patients (44%), affecting 10 of 18 patients (56%) with typical occlusion and 1 of 7 (14%) with atypical occlusion. During follow‐up, three patients (12%) experienced ischemic stroke and, three (12%) had TIA. Functional status changed in 16 patients (64%), with improvement in 12 and decline in four. Categorically, six patients (24%) transitioned to a favorable outcome (mRS ≤2), while three (12%) shifted to an unfavorable one (two had underlying malignancies). Conclusion Endovascular revascularization offers a salvage option for patients with symptomatic CICAO who fail medical therapy. While the procedure can reduce recurrent ischemia and improve functional outcomes, it carries procedural risks, especially in cases with typical occlusion. Patients with atypical occlusions showed higher success rates and fewer complications, suggesting they may benefit most from this approach. Careful patient selection remains critical, and further studies are needed to refine indications and improve safety.

Introduction Post‐market and multicenter studies report low complete occlusion rates (41‐49%) and higher retreatment rates (13%) following WEB deployment, compared to 3.8% with microsurgical clipping. While retreatment after WEB has been shown to be technically feasible, data on final angiographic outcomes remain limited. We performed a retrospective analysis of prospective databases from 14 cerebrovascular centers in the US to compare the safety and efficacy of retreatment versus continued observation for residual and recurrent aneurysms after initial WEB deployment. Materials/Methods Multinomial logistic regression was used to identify baseline characteristics of untreated and residual/recurrent aneurysms that may act as confounders, which then underwent propensity scored matching (PSM). Results Among 211 patients (125 observed, 86 retreated), retreatment was more common in initially ruptured aneurysms (p<0.001), which showed higher recurrence (p=0.036) and sac‐dominant residuals (p=0.004). These were primarily due to WEB compression on follow‐up (p=0.001), rather than incomplete occlusion with an appropriately sized device (p<0.001). Retreatment was associated with significantly higher rates of complete angiographic occlusion at last follow‐up compared to observation alone (p<0.001), a finding that remained consistent across subgroups defined by initial unruptured status, residual type, and recurrence patterns (all p<0.05). Clipping demonstrated higher, though statistically insignificant, rates of complete occlusion; flow diversion and stent‐assisted coil embolization yielded comparable complete occlusion rates at follow‐up. After propensity score matching, retreatment remained significantly associated with higher rates of complete angiographic occlusion (all p<0.05), with comparable outcomes observed between clipping and various endovascular approaches as above. Conclusion Retreatment improved complete occlusion rates; however, no aneurysmal hemorrhages occurred in either group. Further intervention may be unnecessary when the WEB device—whether compressed or intact (BOSS 0/1)—adequately protects the dome. In cases where WEB compression significantly exposes the aneurysm wall, stent‐assisted coiling or flow diversion can be performed safely and successfully, depending on vascular anatomy and surgeon preference. image image

Objective To assess the impact of renal replacement therapy in people with lupus nephritis (LN)–associated end‐stage kidney disease (ESKD) and support the development of the 2024 American College of Rheumatology LN treatment guidelines. Methods We conducted a systematic literature review and meta‐analysis to address three Population, Intervention, Comparison, and Outcome (PICO) questions related to renal replacement therapy for ESKD due to LN, including comparisons of kidney transplant versus dialysis, hemodialysis versus peritoneal dialysis, and preemptive kidney transplant versus no preemptive kidney transplant. Outcomes of interest included mortality, cardiovascular (CV) events, infections, lupus flares, disease‐related damage, graft failure, and quality of life. We conducted a meta‐analysis and analyzed hazard ratios for time‐to‐event analyses and risk ratios for dichotomous outcomes, as well as absolute risk estimates. Results Sixteen comparative observational studies addressed at least one of the three PICO questions. Kidney transplant was found to reduce the risks of all‐cause mortality, CV mortality, infection‐related mortality, and CV events compared with dialysis (high certainty). Dialysis modality (peritoneal vs hemodialysis) was not associated with mortality (high certainty) or with other outcomes of infection, CV complications, and systemic lupus erythematosus flares (low certainty). Preemptive kidney transplant was associated with lower risks of graft failure and mortality (low certainty). Conclusion This systematic review identified improved outcomes with kidney transplant versus dialysis for people with LN‐associated ESKD and potential benefits of preemptive kidney transplant. This evidence supports the use of kidney transplant as a preferred renal replacement therapy for people with LN‐ESKD.

Global surgical collaboration presents opportunities for knowledge exchange, but it also highlights the inequities that influence how surgery is practiced across different contexts. As a Latino surgeon trained in a high-income country, I reflect on my experience at a multidisciplinary, Spanish-language conference in Mexico City that brought together over 600 participants from Mexico and six Latin American countries. The program spanned cholecystectomy, bariatric surgery, hepatology, anesthesia, and interventional radiology, with survey results showing that 87% of attendees reported increased knowledge and 98% intended to apply new practices. Yet, financial constraints, limited time, and lack of institutional support remained significant barriers. For me, the experience was both professional and deeply personal. Teaching exclusively in Spanish affirmed cultural belonging and highlighted language as a tool of equity. At the same time, it underscored the systemic nature of barriers in low- and middle-income countries, where adopting new techniques depends not only on interest or skill but on resources, infrastructure, and institutional support. Standing at the intersection of privilege and solidarity, I felt both pride in contributing and discomfort at the inequities that persist. This reflection suggests that global surgical engagement must move beyond episodic exchanges toward sustained, equitable partnerships that are linguistically accessible, culturally grounded, and structurally supported. Surgery itself exists in two worlds, the technical and the systemic. Embracing that duality can strengthen our collaborations and shift the measure of surgical impact from the number of cases completed to the number of bridges built.

Importance The ideal duration of androgen deprivation therapy (ADT) for treating localized prostate cancer is unknown due to variable adherence and treatment durations tested in clinical trials. Objective To determine the ideal duration of ADT for patients with prostate cancer treated with radiotherapy. Data Sources This individual patient data meta-analysis of 13 randomized phase 3 clinical trials evaluated the use of radiotherapy alone or with ADT. It included patients with a median follow-up of 11.3 (IQR, 9.5-14.5) years and ADT duration of 0 to 36 months. Most patients (7392 [72%]) included had National Comprehensive Cancer Network high-risk or very high-risk disease. Study Selection For this meta-analysis, a systematic literature search from 1980 to 2020 was performed in trial registries (Cochrane Central Register of Controlled Trials and ClinicalTrials.gov), MEDLINE (1966-2020), Embase (1982-2020), Web of Science, and Scopus to identify trials. Data Extraction and Synthesis Intention-to-treat and as-treated analyses were performed. The number needed to treat to prevent 1 distant metastasis at 10 years was calculated based on prognostic risk group. The analyses were conducted from January 5 to August 15, 2023. Main Outcomes and Measures The primary end point for this study was overall survival, defined as time to death or last follow-up from randomization. Secondary end points included biochemical recurrence, distant metastasis (DM), prostate cancer–specific mortality, and other-cause mortality. Results The median (IQR) age among the 10 266 male patients was 70 (65-74) years. Longer durations of ADT were associated with nonlinear improvement in relative benefits of DM, prostate cancer–specific mortality, and overall survival, with reduced estimated benefits beyond 9 to 12 months of ADT based on the end point. There was a near-linear increase in other-cause mortality associated with long-term ADT use (hazard ratio, 1.28; 95% CI, 1.09-1.50; P = .002 for 28 vs 0 months of ADT). The optimal ADT duration based on 10-year DM was 0, 6, 12 months, and undefined for patients with 1 intermediate-risk factor, 2 or more intermediate-risk factors, and National Comprehensive Cancer Network high-risk and very high-risk disease, respectively. Conclusions and Relevance The results of this meta-analysis suggest that, for men with localized prostate cancer treated with definitive radiotherapy and ADT, there are relative and absolute benefits from increasing durations of ADT that help provide individualized risk estimates.

OBJECTIVE The implementation of robotics and spinal anesthesia (SA) in spine surgery is rapidly expanding, offering significant benefits for an increasingly complex and aging patient population with degenerative spinal disease. Here, the authors present the largest cohort to date evaluating the combined use of these two techniques in minimally invasive (MIS) transforaminal lumbar interbody fusion (TLIF). METHODS The authors retrospectively analyzed surgical outcomes of a series of patients who underwent robot-assisted (RA)–MIS TLIF under SA and general anesthesia (GA) at their institution from 2018 to 2024. Primary outcomes included operative times and postoperative pain intensity. Secondary outcomes included estimated blood loss, intraoperative complications, postoperative functional status, length of stay (LOS), and discharge status. To address potential confounders, a 1:1 propensity score–matching and regression analysis was implemented. Statistical analyses were conducted using Python. RESULTS A total of 209 patients underwent RA-MIS TLIF, with 31 (14.83%) receiving SA and 178 (85.17%) GA. After propensity score matching, the SA cohort demonstrated significantly shorter median total operating room (OR) time, total procedure time, time from entering the OR to skin incision, and time from closure to leaving the OR (all p < 0.01). Additionally, postoperative pain scores were significantly lower (p < 0.01), and LOS was significantly shorter (p < 0.01) in the SA cohort. Regression analysis, adjusting for potential confounders, further supported these findings. CONCLUSIONS RA-MIS TLIF fusion under SA is a safe and effective approach that significantly reduces operative time, postoperative pain, and hospital LOS in patients undergoing surgery for degenerative lumbar spine disease.

Importance Total pancreatectomy (TP) is indicated for advanced pancreatic cancer or multifocal tumors. Furthermore, TP may be performed to avoid the risk of pancreatic fistula in selected patients to improve the perioperative risk profile. Objective To define reference values for TP based on a low-risk cohort treated at expert centers. Design, Setting, and Participants This multicenter study analyzed outcomes from patients undergoing primary TP for malignant or benign lesions from 25 international expert centers from January 2017 to November 2023. Low-risk patients undergoing TP (LR-TP) were without vascular resections or significant comorbidities. Exposures TP. Main Outcomes and Measures Twenty reference values were derived from the 75th or the 25th percentile of the median values of all centers. Outcomes of LR-TP were compared with a cohort of TP with vascular resection, TP due to high-risk pancreatic anastomosis, and the benchmark values for low-risk pancreatoduodenectomy. Results Of 994 patients, 333 (33.5%; median [IQR] age, 66 [58-72] years; 171 male [51.4%]) qualified as the LR-TP cohort. Reference values included blood loss (≤1000 mL), major complications (≤37%), 3-month postoperative mortality (&amp;lt;6%), and retrieved lymph nodes (≥29). Compared with TP with vascular resections, reference cutoffs were not met for major complications (51% vs LR-TP ≤37%) and 90-day mortality (11% vs LR-TP ≤6%). For TP due to high-risk anastomosis, failure to rescue rate (38% vs ≤6%) and 90-day mortality (11% vs LR-TP ≤6%) were not met. Compared with pancreatoduodenectomy, reference values for postoperative mortality were 3 times higher for LR-TP (≤2% vs ≤6%) and less for resected lymph nodes (≥16 vs ≥29). Conclusions and Relevance This case-control study provided global reference values for TP, indicating significantly higher postoperative morbidity and mortality compared with pancreatoduodenectomy. Perioperative morbidity of TP was especially increased in patients with vascular resections. These reference values can serve for quality control of pancreatic surgery.